JO
BNTX icon

John Overdeck’s BioNTech BNTX Stock Holding History

John Overdeck’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34,800
Closed -$8.97M – 2822
2021
Q4 		$8.97M Buy
34,800
+13,200
+61% +$3.62M 0.02% 855
2021
Q3 		$5.9M Buy
21,600
+7,300
+51% +$2.32M 0.01% 1118
2021
Q2 		$3.2M Buy
+14,300
New +$2.7M 0.01% 1501

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

John Overdeck's BNTX Position: Q2 2026 in Review

John Overdeck increased its BioNTech (BNTX) stake by 76% in Q2 2026, buying an estimated $11.9M and bringing the position to 292,614 shares worth $27.2M. The position accounts for 0.02% of the portfolio, ranked #863.

John Overdeck first reported a position in BNTX in Q4 2020 and has held it in 11 quarters since. The position peaked at $62.3M in Q2 2021. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • John Overdeck held 292,614 shares of BioNTech worth $27.2M as of Q2 2026.
  • John Overdeck bought 126,435 BioNTech shares in Q2 2026, an estimated $11.9M.
  • BioNTech made up 0.02% of John Overdeck's portfolio in Q2 2026, its #863 holding.
  • John Overdeck first reported a position in BioNTech in Q4 2020 and has held it in 11 quarters since.
  • John Overdeck's BioNTech position peaked at $62.3M in Q2 2021.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.